The 59 references in paper K. Pavlov A., Ye. Dubova A., O. Mishnyov D., A. Shchegolev I., К. Павлов А., Е. Дубова А., О. Мишнёв Д., А. Щёголев И. (2007) “Медиаторные взаимодействия при остром респираторном дистресс-синдроме // Mediator Interactions in Acute Respiratory Distress Syndrome” / spz:neicon:reanimatology:913

1
Мишнёв О. Д., Щёголев А. И. Патологическая анатомия ОРДС. В кн.: Гельфанд Б. Р. , Кассиль В. Л. ( ред. ) Острый респираторный дис! тресс!синдром. М.: Литтерра; 2007. 48—67.
(check this in PDF content)
2
Руднов В. А., Левит А. Л., Бутров А. В., Звягин А. А.Эпидемиология и факторы риска. Там же. 26—28.
(check this in PDF content)
3
Ricou B.Acute lung injury (ALI) and acute respiratory distress syn! drome (ARDS): Mediator network. Intensivmed. 1998; 35: 10—21.
(check this in PDF content)
4
Игнатенко О. В., Проценко Д. Н., Ярошецкий А. И., Гельфанд Б. Р. Вен! тилятор!ассоциированное повреждение легких. Там же. 114—126.
(check this in PDF content)
5
Marks J. D., Berman!Marks C., Luce J. M. et al.Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effect of methylprednisolone admin! istration. Amer. Rev. Respir. Dis. 1990; 141: 94—97.
(check this in PDF content)
6
Pierce J. D., Pierce J., Stremming S., Fakhari M.The role of apoptosis in respiratory diseases. Clin. Nurse. Spec. 2007; 21 (1): 22—30.
(check this in PDF content)
7
Mukhopadhyay S., Hoidal J. R., Mukherjee T. K.Role of TNF!alpha in pulmonary pathophysiology. Respir. Res. 2006; 7: 125.
(check this in PDF content)
8
Pugin J., Ricou B., Steinberg K. P. et al.Proinflammatory activity in bronchoalveolar lavagefluid from ARDS patients: a prominent role for interleukin!1. Amer. J. Respir. Crit. Care. Med. 1996; 153: 1850—1856.
(check this in PDF content)
9
Zimmerman J. J.Understanding another acute respiratory distress syn! drome. Crit. Care Med. 2007; 35 (3): 974—975.
(check this in PDF content)
10
Donnelly S. C., Strieter R. M., Kunkel S. L. et al.Interleukin!8 and devel! opment of adult distress syndrome in at risk patient groups. Lancet 1993; 41: 643—647.
(check this in PDF content)
11
Te r m i n e l l a L . , S h a r m a G . Diagnostic studies in patients with acute res! piratory distress syndrome. Semin. Thorac. Cardiovasc. Surg. 2006; 18 (1): 2—7.
(check this in PDF content)
12
Mulligan M. S., Jones M. L., Vaporciyan A. A. et al.Protective effects of IL!4 and IL!10 against immune complex!induced lung injury. J. Immunol. 1993; 151: 5666—5674.
(check this in PDF content)
13
Donnelly S. C., Strieter R. M., Reid P. T. et al.The association between mortality rates and decreased concentrations of interleukin!10 and interleukin!1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann. Intern. Med. 1996; 125: 191—196.
(check this in PDF content)
14
Frank J. A., Parsons P. E., Matthay M. A.Pathogenetic significance of biological markers of ventilator!associated lung injury in experimental and clinical studies. Chest 2006; 130 (6): 1906—1914.
(check this in PDF content)
15
Ulich T. R., Yin S., Guo K. et al.Intratracheal injection of endotoxin and cytokines II. Interleukin!6 and transforming growth factor!binhibit acute inflammation. Amer. J. Pathol. (USA) 1991; 138: 1097—1101.
(check this in PDF content)
16
Shenkar R., Coulson W. F., Abraham E.Anti!transforming growth factor! b monoclonal antibodies prevent lung injury in hemorrhaged mice. Amer. J. Respir. Cell. Mol. Biol. 1994; 11: 351—357.
(check this in PDF content)
17
Пальцев М. А.(ред.) Введение в молекулярную медицину. М.: Ме! дицина; 2004.
(check this in PDF content)
18
Heinrich P. C., Castell J. V., Andus T.Interleukin!6 and the acute phase response. Biochem. J. 1990; 265: 621—636.
(check this in PDF content)
19
Пальцев М. А., Иванов А. А., Северин С. Е.Межклеточные взаимо! действия. М.: Медицина; 2003.
(check this in PDF content)
20
Miyake Y., Kaise H., Isono K., Koseki H.Protective role of macrophages in noninflammatory lung injury caused by selective ablation of alveolar epithelial type II. Cells. J. Immunol. 2007; 178 (8): 5001—5009.
(check this in PDF content)
21
Heffner J. E., Repine J. E.Pulmonary strategies of antioxidant defense. Amer. Rev. Respir. Dis. 1989; 140: 531—554.
(check this in PDF content)
22
Wa r e L . B .Pathophysiology of acute lung injury and the acute respira! tory distress syndrome. Semin Respir. Crit. Care Med. 2006; 27 (4): 337—349.
(check this in PDF content)
23
Ishii Y., Partridge C. A., Del Vecchio P. J., Malik A. B.Tu m o r n e c r o s i s f a c ! tor — a mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. J. Clin. Invest. 1992; 89: 794—802.
(check this in PDF content)
24
Wa r n e r B . B . , B u r h a n s M . S . , C l a r k J . C . , W i s p J . R .Tu m o r n e c r o s i s f a c t o r — a increases Mn!SOD expression: protection against oxidant injury. Amer. J. Physiol. 1991; 260: L296—L301.
(check this in PDF content)
25
Motterlini R., Foresti R., Intaglietta M., Winslow R. M.NO!mediated acti! vation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Amer. J. Physiol. 1996; 270: H107—H114.
(check this in PDF content)
26
Kubes P., Granger D. N.Nitric oxide modulates microvascular perme! ability. Amer. J. Physiol. 1992; 262: H611—H615.
(check this in PDF content)
27
Hill M. E., Bird I. N., Daniels R. H. et al.Endothelial cell!associated platelet!activating factor primes neutrophils for enhanced superoxide production and arachidonic acid release during adhesion to but no transmigration across IL!1 b!treated endothelial monolyers. J. Immunol. (USA) 1994; 153: 3673—3683.
(check this in PDF content)
28
Jiang Y., Xu J., Zhou C., Wu Z.Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am. J. Respir. Crit. Care Med. 2005; 171: 850—857.
(check this in PDF content)
29
Henson P. M., Barnes P. J., Banks!Schlegel S. P. Platelet!activation factor: role in pulmonary injury and dysfunction and blood abnormalities (NHLB Wo r k s h o p s u m m a r y ) . A m e r . R e v. R e s p i r . D i s . 1 9 9 2 ; 1 4 5 : 7 2 6 — 7 3 1 .
(check this in PDF content)
30
Rabinovici R., Bugelski P. J., Esser K. M. et al.ARDS!like lung injury pro! duced by endotoxin in platelet!activating factor!primed rats. J. Appl. Physiol. 1993; 74: 1791—1802.
(check this in PDF content)
31
Matsumoto K., Taki F., Kondoh Y. et al.Plateletactivating factor in bron! choalveolar lavage fluid of patients with adult respiratory distress syn! drome. Clin. Exp. Pharmacol. Physiol. 1992; 19: 509—515.
(check this in PDF content)
32
Belperio J. A., Keane M. P., Lynch J. P., Strieter R. M.The role of cytokines during the pathogenesis of ventilator!associated and ventila! tor!induced lung injury. Semin. Respir. Crit. Care Med. 2006; 27 (4): 350—364.
(check this in PDF content)
33
Smith C. S., Parker L., Shearer W. T.Cytokine regulation by plateletac! tivating factor in a human B cell line. J. Immunol. (USA) 1994; 153: 3997—4005.
(check this in PDF content)
34
Moya F. R., Hoffman D. R., Zhao B., Johnston J. M.Platelet!activating factor in surfactant preparations. Lancet 1993; 341: 858—860.
(check this in PDF content)
35
Puneet P., Moochhala S., Bhatia M. Chemokines in acute respiratory dis! tress syndrome Amer. J. Physiol. Lung Cell Mol. Physiol. 2005; 288: L3—L15.
(check this in PDF content)
36
Campbell E. J., Senior R. M., Welgus H. G.Extracellular matrix injury during lung inflammation. Chest 1987; 92: 161—167.
(check this in PDF content)
37
Киров М. Ю., Недашковский Э. В., Кассиль В. Л., Багдатьев В. Е.Эти! ология и патогенез. В кн.: Гельфанд Б. Р., Кассиль В. Л. (ред.) Ост! рый респираторный дистресс!синдром. М.: Литтерра; 2007. 29—39.
(check this in PDF content)
38
Wo e s s n e r J . F. Matrix metalloproteinases and their inhibitors in connec! tive tissue remodeling. FASEB. J. 1991; 5: 2145—2154.
(check this in PDF content)
39
Elkington P. T. G., Friedland J. S.Matrix metalloproteinases in destruc! tive pulmonary pathology. Thorax 2006; 61: 259—266.
(check this in PDF content)
40
To r i i K . , I i d a K . I . , M i y a z a k i Y . e t a l .High concentrations of matrix met! alloproteinases in bronchoalveolar lavaga fluid of patients with adult respiratory distress syndrome. Amer. J. Respir. Crit. Care Med. 1997; 155: 43—46.
(check this in PDF content)
41
Perez R. L., Roman J.Fibrin enhances the expression of IL!1 by human peripheral blood mononuclear cells. Implications in pulmonary inflam! mation. J. Immunol. 1995; 154: 1879—1887.
(check this in PDF content)
42
Lotz M., Guerne P. A.Interleukin!6 induces the synthesis of tissue inhibitor of metalloproteinases!1/erythroid potentiating activity (TIMP!1/EPA). J. Biol. Chem. 1991; 266: 2017—2020.
(check this in PDF content)
43
Lacraz S., Nicol L., Galve!de Rochemonteix B. et al.Suppression of met! alloproteinase biosynthesis in human alveolar macrophages by inter! leukin!4. J. Clin. Invest. 1992; 90: 383—388.
(check this in PDF content)
44
Jawa R. S.What is new in cytokine research related to trauma. Critical Care. J. Intens. Care Med. 2006; 21 (2): 63—85.
(check this in PDF content)
45
Ve n t r i c e E . A . , M a r t i !S i s t a c O . , G o n z a l v o R . , V i l l a g r a A . Molecular and biophysical mechanisms and modulation of ventilator!induced lung injury. Med. Intensiva 2007; 31 (2): 73—82.
(check this in PDF content)
46
Fuchs!Buder T., De Moerloose Ph., Ricou B. et al.Time course of procoag! ulant activity and d!dimer in bronchoalveolar fluid of patients at risk for or with ARDS. Amer. J. Respir. Crit. Care Med. 1996; 153: 164—167.
(check this in PDF content)
47
Medford A. R. L., Millar A. B.Va s c u l a r e n d o t h e l i a l g r o w t h f a c t o r (VEGF) in acute lung injury (ALI) and acute respiratory distress syn! drome (ARDS): paradox or paradigm? Thorax 2006; 61: 621—626.
(check this in PDF content)
48
Murphy G., Atkinson S., Ward R. et al.The role of plasminogen activa! tors in the regulation of connective tissue metalloproteinases. In Ann.: N.Y. Acad. Sci. 1992; 667. 1—12.
(check this in PDF content)
49
Pison U., May M., Neuendank A. et al.Host defense capacities of pul! monary surfactant: Evidence for non!surfactant functions of the surfac! tant system. Eur. J. Clin. Invest. 1994; 24: 586—599.
(check this in PDF content)
50
Baudouin S. V. Surfactant medication for acute respiratory distress syn! drome. Thorax 1997; 52: S9—15.
(check this in PDF content)
51
Rooney S. A., Young S. L., Mendelson C. R.Molecular and cellular pro! cessing of lung surfactant. FASEB J. 1994; 8: 957—967.
(check this in PDF content)
52
Greene K. E., Gardai S., Henson P. M.SP!A and SP!D inhibit sponta! neous neutrophil apoptosis via activation of the PI!3 kinase/AKT. Amer. J. Respir. Crit. Care Med. 2001; 163: 23.
(check this in PDF content)
53
Bellingan G. J.The pathogenesis of ALI/ARDS. Thorax 2002; 57: 540—546.
(check this in PDF content)
54
Ve n k i t a r a m a n A . R . , H a l l S . B . , W h i t s e t t J . A . , N o t t e r R . H .Enhancement of biophysical activity of lung surfactant extracts and phospholipid! apoprotein mixtures by surfactant protein. Chem. Phys. Lipids. 1990; 56: 185—194.
(check this in PDF content)
55
Horowitz S., Watkins R. H., Auten R. L. et al.Differential accumulation of surfactant protein A, B, and C mRNAs in two epithelial cell types of hyperoxic lung. Amer. J. Respir. Cell Mol. Biol. 1991; 5: 511—515.
(check this in PDF content)
56
Baker C. S., Evans T. W., Randle B. J. et al.Damage to surfactant!specif! ic protein in acute respiratory distress syndrome. Lancet 1999; 353: 1232—1237.
(check this in PDF content)
57
Balibrea!Cantero J. L., Arias!Diaz L., Garcia C. et al.Effect of pentoxi! fylline on the inhibition of surfactant synthesis induced by TNF!a in human type II pneumocytes. Amer. J. Respir. Crit. Care 1994; 149: 699—706.
(check this in PDF content)
58
Гельфанд Б. Р., Кассиль В. Л. (ред.) Острый респираторный дис! тресс!синдром. М.: Литтерра; 2007. 232.
(check this in PDF content)
59
Гельфанд Б. Р. , Игнатенко О. В. , Недашковский Э. В. , Киров М. Ю. Инфузионная терапия. Там же. 190—200. Поступила 02.05.07
(check this in PDF content)